
Jaime M. Yassif, Ph.D.
Vice President, Global Biological Policy and Programs
Rapid advances in AI and its convergence with the life sciences present new biosecurity risks that require innovative solutions and action by governments, technologists and other key stakeholders around the world.
Provide a global forum to develop a shared understanding of AI-related biosecurity risks and technical solutions to address them. Promote adoption of national and global governance for AIxBio capabilities.
Adoption and implementation of effective governance frameworks and best practices that enable beneficial applications of AI in the life sciences while reducing biosecurity risks.
The AIxBio Global Forum provides a platform for international experts, policymakers, and other key stakeholders to identify and reduce biosecurity risks associated with the convergence of artificial intelligence (AI) and the life sciences.
The Forum has three main objectives:
To achieve these goals, the Forum includes a diverse international group of policy makers along with experts from organizations that develop AI models, biosecurity and AI safety communities, and the bioscience research community. Technical Working Groups enable the Forum to identify best practices and develop technical guardrails to reduce risks that AIxBio capabilities will be misused. This work is aligned with an evolving research agenda designed to provide a comprehensive map of open questions and opportunities to explore in this area. The Forum will conduct analyses, release statements, and provide recommendations to shape national and global governance strategies for AIxBio capabilities–with the ultimate goal of safeguarding the benefits of these powerful technologies.
The AIxBio Global Forum is currently supported by two technical Working Groups, which produce outputs that are shared with the full Forum for further discussion and consideration. One working group is focused on Biological Design Tools and the other on Horizon Scanning, Risk Assessment, and Evaluations. The Forum’s structure ensures that its statements and recommendations carry the full weight of international consideration, while remaining focused and actionable. This approach enables the Forum to issue helpful guidance that can shape policy and practice in this rapidly evolving field.
NTI | bio has responded to the U.S. government request for information (RFI) related to the Artificial Intelligence (AI) Action Plan outlined by President Donald Trump’s January 2025 Executive Order, providing input on the highest priority actions to maintain and extend U.S. global leadership on AI.
The official side event focused on safeguarding capabilities at the convergence of AI with the life sciences.
NTI | bio convened two technical working groups this fall to address critical challenges at the intersection of AI and the life sciences, bringing together more than 50 international experts from major AI companies, academic institutions, and biosecurity organizations.
NTI | bio convened more than 25 high-level biosecurity professionals, AI experts, and policymakers for the inaugural meeting of the International AI-Bio Forum.
To reduce biosecurity risks that arise at the intersection of AI and the life sciences, NTI | bio convened experts in synthetic biology, machine learning, bioinformatics, and international security policy to outline steps toward establishing an international AI-Bio Forum.